Viatris Inc (VTRS) is the 29th largest of 300 Generic Drugs companies by market capitalisation, at 19.18 Bn, behind STERIS plc at 21.14 Bn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.61 Bn | 61.22 | 0.00 Mn | 38.95 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.18 Bn | -46.71 | 0.00 Mn | 18.30 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.85 Bn | 780.84 | 0.00 Mn | 9.68 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.48 Bn | 25.45 | 0.00 Mn | 5.35 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -2.16 | 0.00 Mn | 0.52 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -5.40 | 0.00 Mn | 1.36 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.78 | 0.00 Mn | 1.13 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | 11.91 | 0.00 Mn | 0.70 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -91.42 | 0.00 Mn | 0.36 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -434.89 | 0.00 Mn | 0.18 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.02 | 0.00 Mn | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.00 Mn | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.48 | 0.00 Mn | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.78 | 0.00 Mn | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.92 | 0.00 Mn | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.24 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.59 | 0.00 Mn | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.38 | 0.00 Mn | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | 0.00 Mn | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 0.00 Mn | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 646.71 Bn | 30.74 | 0.00 Mn | 625.95 Bn |
| 25 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 442.22 Bn | 70.02 | 0.00 Mn | 435.65 Bn |
| 26 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 366.92 Bn | 115.78 | 0.00 Mn | 359.78 Bn |
| 27 | PG | PROCTER & GAMBLE Co | secondary | S-10 | Household and Personal Products | SG-05 | 333.44 Bn | 20.66 | 0.00 Mn | 323.50 Bn |
| 28 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.90 Bn | 9.27 | 0.00 Mn | 259.21 Bn |
| 29 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.92 Bn | 31.95 | 0.00 Mn | 220.85 Bn |
| 30 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 184.08 Bn | 33.93 | 0.00 Mn | 178.48 Bn |
| 31 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.27 Bn | -62.62 | 0.00 Mn | 178.09 Bn |
| 32 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 159.20 Bn | 36.45 | 0.00 Mn | 147.50 Bn |
| 33 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.28 Bn | 30.03 | 0.00 Mn | 124.42 Bn |
| 34 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.44 Bn | 11.25 | 0.00 Mn | 45.06 Bn |
| 35 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.11 Bn | -24.95 | — | 44.11 Bn |
| 36 | ADM | Archer-Daniels-Midland Co | secondary | S-07 | Agribusiness | SG-03 | 41.67 Bn | 23.42 | 0.00 Mn | 32.09 Bn |
| 37 | KVUE | Kenvue Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 34.18 Bn | 20.61 | 0.00 Mn | 33.07 Bn |
| 38 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.03 Bn | 52.92 | 0.00 Mn | 32.57 Bn |
| 39 | KMB | Kimberly Clark Corp | secondary | S-11 | Household and Personal Products | SG-05 | 32.86 Bn | 18.50 | 0.00 Mn | 31.90 Bn |
| 40 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.22 Bn | 37.41 | 0.00 Mn | 29.93 Bn |
| 41 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.68 Bn | 9.38 | 0.00 Mn | 29.00 Bn |
| 42 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.94 Bn | -20.17 | 0.00 Mn | 29.94 Bn |
| 43 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.61 Bn | 14.44 | 0.00 Mn | 27.50 Bn |
| 44 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 28.15 Bn | -32.16 | 0.00 Mn | 26.99 Bn |
| 45 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.38 Bn | 15.74 | 0.00 Mn | 20.85 Bn |
| 46 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 24.04 Bn | 43.76 | 0.00 Mn | 23.61 Bn |
| 47 | CHD | Church & Dwight Co Inc /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 22.56 Bn | 30.30 | 0.00 Mn | 22.31 Bn |
| 48 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.60 Bn | 73.98 | 0.00 Mn | 21.03 Bn |
| 49 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.50 Bn | 16.40 | 0.00 Mn | 18.84 Bn |
| 50 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.14 Bn | 26.16 | 0.00 Mn | 20.66 Bn |
| 51 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.58 Bn | 22.08 | 0.00 Mn | 15.19 Bn |
| 52 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.11 Bn | 16.06 | 0.00 Mn | 13.50 Bn |
| 53 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.52 Bn | 16.87 | 0.00 Mn | 13.68 Bn |
| 54 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.44 Bn | 40.54 | 0.00 Mn | 13.83 Bn |
| 55 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.33 Bn | -56.06 | 0.00 Mn | 13.13 Bn |
| 56 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.81 Bn | 557.12 | 0.00 Mn | 10.66 Bn |
| 57 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.15 Bn | 224.07 | 0.00 Mn | 11.84 Bn |
| 58 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 0.00 Mn | 10.63 Bn |
| 59 | CLX | Clorox Co /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 10.99 Bn | 18.28 | 0.00 Mn | 10.84 Bn |
| 60 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.88 Bn | -70.78 | 0.00 Mn | 10.56 Bn |
| 61 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.60 Bn | -67.29 | 0.00 Mn | 10.48 Bn |
| 62 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.14 Bn | -26.59 | — | 9.38 Bn |
| 63 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.85 Bn | 26.25 | 0.00 Mn | 9.32 Bn |
| 64 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.78 Bn | -13.34 | 0.00 Mn | 8.62 Bn |
| 65 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 66 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.33 Bn | -43.94 | 0.00 Mn | 7.27 Bn |
| 67 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.07 Bn | -48.22 | — | 9.07 Bn |
| 68 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 0.00 Mn | 8.99 Bn |
| 69 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 8.70 Bn | 34.10 | 0.00 Mn | 8.18 Bn |
| 70 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.57 Bn | 114.43 | 0.00 Mn | 6.91 Bn |
| 71 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.00 Mn | 9.09 Bn |
| 72 | CELH | Celsius Holdings, Inc. | secondary | S-03 | Beverages | SG-01 | 7.24 Bn | 120.65 | 0.00 Mn | 6.60 Bn |
| 73 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.58 Bn | 23.90 | 0.00 Mn | 5.99 Bn |
| 74 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.45 Bn | -39.57 | 0.00 Mn | 6.07 Bn |
| 75 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.43 Bn | -45.26 | 0.00 Mn | 5.59 Bn |
| 76 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.34 Bn | -707.43 | 0.00 Mn | 6.34 Bn |
| 77 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.19 Bn | -142.37 | 0.00 Mn | 6.07 Bn |
| 78 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.16 Bn | 0.08 | — | 6.16 Bn |
| 79 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.08 Bn | 43.84 | 0.00 Mn | 5.79 Bn |
| 80 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.86 | 0.00 Mn | 5.65 Bn |
| 81 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.82 Bn | 29.52 | 0.00 Mn | 4.47 Bn |
| 82 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.00 Bn | -17.40 | — | 5.00 Bn |
| 83 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.00 Mn | 4.09 Bn |
| 84 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.77 Bn | 12.54 | 0.00 Mn | 3.81 Bn |
| 85 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.70 | — | 4.67 Bn |
| 86 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.24 Bn | -11.99 | — | 4.24 Bn |
| 87 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.09 Bn | -8.00 | 0.00 Mn | 4.09 Bn |
| 88 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.08 Bn | 11.50 | 0.00 Mn | 3.86 Bn |
| 89 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.03 Bn | -46.77 | — | 4.03 Bn |
| 90 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 0.00 Mn | 3.59 Bn |
| 91 | BBWI | Bath & Body Works, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 3.88 Bn | 5.86 | 0.00 Mn | 3.09 Bn |
| 92 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 0.00 Mn | 3.09 Bn |
| 93 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.18 | — | 3.80 Bn |
| 94 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.63 Bn | -77.26 | 0.00 Mn | 3.18 Bn |
| 95 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.19 | 0.00 Mn | 2.46 Bn |
| 96 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | -7.79 | 0.00 Mn | 2.88 Bn |
| 97 | IPAR | Interparfums Inc | secondary | S-12 | Household and Personal Products | SG-05 | 3.57 Bn | 17.40 | 0.00 Mn | 3.36 Bn |
| 98 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.98 Bn | -11.02 | 0.00 Mn | 2.46 Bn |
| 99 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.91 Bn | -8.53 | 0.00 Mn | 2.47 Bn |
| 100 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.87 Bn | -11.07 | 0.00 Mn | 2.87 Bn |
| 101 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.01 | 0.00 Mn | 2.12 Bn |
| 102 | WDFC | Wd 40 Co | secondary | S-10 | Household and Personal Products | SG-05 | 2.70 Bn | 30.24 | 0.00 Mn | 2.64 Bn |
| 103 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.68 Bn | -22.60 | 0.00 Mn | 2.58 Bn |
| 104 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | -81.77 | — | 2.65 Bn |
| 105 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -7.54 | — | 2.64 Bn |
| 106 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.00 Mn | -3.18 Bn |
| 107 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.63 | — | 2.60 Bn |
| 108 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.00 Mn | -2.62 Bn |
| 109 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | -28.53 | 0.00 Mn | 2.06 Bn |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.51 | 0.00 Mn | 1.60 Bn |
| 111 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.31 Bn | -6.02 | 0.00 Mn | 1.96 Bn |
| 112 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -3.90 | — | 2.02 Bn |
| 113 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.06 | 0.00 Mn | 2.28 Bn |
| 114 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.19 Bn | -41.33 | — | 1.88 Bn |
| 115 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.13 Bn | 12.83 | 0.00 Mn | 2.00 Bn |
| 116 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.71 | 0.00 Mn | 1.66 Bn |
| 117 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 0.00 Mn | 2.03 Bn |
| 118 | SPB | Spectrum Brands Holdings, Inc. | secondary | S-04 | Branded Foods | SG-02 | 2.00 Bn | 23.64 | 0.00 Mn | 1.74 Bn |
| 119 | PRGO | PERRIGO Co plc | secondary | S-11 | Household and Personal Products | SG-05 | 2.00 Bn | -1.15 | 0.00 Mn | 1.60 Bn |
| 120 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | 171.75 | 0.00 Mn | 1.61 Bn |
| 121 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | -6.55 | 0.00 Mn | 0.90 Bn |
| 122 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | -192.89 | 0.00 Mn | 1.61 Bn |
| 123 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.89 | 0.00 Mn | 0.97 Bn |
| 124 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 0.00 Mn | 1.26 Bn |
| 125 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.24 | 0.00 Mn | 1.21 Bn |
| 126 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -24.11 | — | 1.46 Bn |
| 127 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -8.62 | — | 1.41 Bn |
| 128 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.05 | 0.00 Mn | 1.32 Bn |
| 129 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.39 Bn | 81.67 | 0.00 Mn | 1.39 Bn |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | -80.40 | 0.00 Mn | 1.26 Bn |
| 131 | NMAX | Newsmax Inc. | secondary | C-05 | Advertising and Media | CG-02 | 1.38 Bn | -17.32 | 0.00 Mn | 1.33 Bn |
| 132 | HLF | Herbalife Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 1.30 Bn | 5.13 | 0.00 Mn | 0.93 Bn |
| 133 | EPC | EDGEWELL PERSONAL CARE Co | secondary | S-11 | Household and Personal Products | SG-05 | 1.24 Bn | -17.95 | 0.00 Mn | 0.85 Bn |
| 134 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -171.65 | 0.00 Mn | 0.97 Bn |
| 135 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | 7.45 | 0.00 Mn | 1.09 Bn |
| 136 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -25.49 | — | 1.00 Bn |
| 137 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -31.10 | 0.00 Mn | 0.88 Bn |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.10 Bn | -5.36 | — | 1.10 Bn |
| 139 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.07 Bn | -4.49 | 0.00 Mn | 1.07 Bn |
| 140 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.03 Bn | -7.57 | 0.00 Mn | 0.96 Bn |
| 141 | RAJAF | TFA Therapeutics, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 1.02 Bn | — | 0.00 Mn | 1.02 Bn |
| 142 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.39 | 0.00 Mn | 0.76 Bn |
| 143 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -69.87 | — | 0.92 Bn |
| 144 | ODD | Oddity Tech Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.95 Bn | 13.02 | 0.00 Mn | 0.66 Bn |
| 145 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.76 | — | 0.74 Bn |
| 146 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -14.89 | 0.00 Mn | 0.75 Bn |
| 147 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -48.72 | — | 0.93 Bn |
| 148 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.75 Bn |
| 149 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -9.98 | 0.00 Mn | 0.83 Bn |
| 150 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.93 | 0.00 Mn | 0.79 Bn |
| 151 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -6.79 | 0.00 Mn | 0.65 Bn |
| 152 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | 15.89 | 0.00 Mn | 0.61 Bn |
| 153 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.47 | 0.00 Mn | 0.55 Bn |
| 154 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.72 Bn | 12.34 | 0.00 Mn | 0.50 Bn |
| 155 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.09 | 0.00 Mn | 0.65 Bn |
| 156 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 0.00 Mn | 0.69 Bn |
| 157 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.65 Bn | — | — | 0.22 Bn |
| 158 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.06 | 0.00 Mn | 0.38 Bn |
| 159 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.14 | 0.00 Mn | 0.54 Bn |
| 160 | HELE | Helen Of Troy Ltd | secondary | D-06 | Household Durables | DG-02 | 0.63 Bn | -1.53 | 0.00 Mn | 0.61 Bn |
| 161 | EVOH | EvoAir Holdings Inc. | secondary | I-14 | Construction Products | IG-03 | 0.63 Bn | -56.89 | 0.00 Mn | 0.62 Bn |
| 162 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.07 | — | 0.62 Bn |
| 163 | HNST | Honest Company, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.62 Bn | -50.60 | 0.00 Mn | 0.51 Bn |
| 164 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -344,822.34 | — | 0.60 Bn |
| 165 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,167.58 | 0.00 Mn | 0.48 Bn |
| 166 | BWMX | Betterware De Mexico, S.A.P.I. De C.V | secondary | S-12 | Household and Personal Products | SG-05 | 0.58 Bn | 10.17 | 0.00 Mn | 0.55 Bn |
| 167 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -16.61 | 0.00 Mn | 0.53 Bn |
| 168 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.93 | — | 0.54 Bn |
| 169 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.55 | 0.00 Mn | 0.45 Bn |
| 170 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.54 | 0.00 Mn | 0.42 Bn |
| 171 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.37 | 0.00 Mn | 0.38 Bn |
| 172 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.45 | 0.00 Mn | 0.22 Bn |
| 173 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 0.00 Mn | 0.24 Bn |
| 174 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.65 | 0.00 Mn | 0.36 Bn |
| 175 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -5.07 | 0.00 Mn | 0.26 Bn |
| 176 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.55 | 0.00 Mn | 0.32 Bn |
| 177 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.39 | — | 0.26 Bn |
| 178 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.28 | 0.00 Mn | 0.42 Bn |
| 179 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -53.19 | — | 0.41 Bn |
| 180 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.11 | 0.00 Mn | 0.19 Bn |
| 181 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -1.23 | 0.00 Mn | 0.20 Bn |
| 182 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -7.21 | 0.00 Mn | 0.28 Bn |
| 183 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 184 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 185 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 0.00 Mn | 0.15 Bn |
| 186 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.15 | 0.00 Mn | 0.27 Bn |
| 187 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -2.68 | 0.00 Mn | 0.14 Bn |
| 188 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | 3.42 | 0.00 Mn | 0.08 Bn |
| 189 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.09 | — | 0.30 Bn |
| 190 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 191 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.64 | 0.00 Mn | 0.15 Bn |
| 192 | USNA | Usana Health Sciences Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.28 Bn | -9.45 | 0.00 Mn | 0.11 Bn |
| 193 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.95 | — | 0.27 Bn |
| 194 | BFNH | Bioforce Nanosciences Holdings, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.26 Bn | -2,541.40 | — | 0.26 Bn |
| 195 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.76 | 0.00 Mn | 0.10 Bn |
| 196 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.06 | 0.00 Mn | 0.14 Bn |
| 197 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | — | 0.00 Mn | 0.05 Bn |
| 198 | NAGE | Niagen Bioscience, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 15.23 | 0.00 Mn | 0.18 Bn |
| 199 | NATR | Natures Sunshine Products Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 12.96 | 0.00 Mn | 0.16 Bn |
| 200 | NUS | Nu Skin Enterprises, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.23 Bn | -1.05 | 0.00 Mn | 0.04 Bn |
| 201 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.02 | 0.00 Mn | -10.84 Bn |
| 202 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.62 | 0.00 Mn | 0.14 Bn |
| 203 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 204 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.35 | 0.00 Mn | 0.22 Bn |
| 205 | PTNM | Pitanium Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.21 Bn | -63.51 | 0.00 Mn | -2.70 Bn |
| 206 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.06 | — | 0.21 Bn |
| 207 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -56.25 | 0.00 Mn | 0.18 Bn |
| 208 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.29 | 0.00 Mn | 0.16 Bn |
| 209 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.58 | — | 0.20 Bn |
| 210 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -29.87 | — | 0.20 Bn |
| 211 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.22 | 0.00 Mn | 0.14 Bn |
| 212 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -37.45 | 0.00 Mn | 0.19 Bn |
| 213 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.44 | — | 0.12 Bn |
| 214 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -46.69 | — | 0.17 Bn |
| 215 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.21 | 0.00 Mn | 0.16 Bn |
| 216 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.16 Bn | -1.84 | 0.00 Mn | 0.12 Bn |
| 217 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.41 | 0.00 Mn | 0.15 Bn |
| 218 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 0.00 Mn | -0.04 Bn |
| 219 | NWOEF | New Oriental Education & Technology Group Inc. | secondary | D-28 | Consumer Services | DG-09 | 0.14 Bn | 0.17 | 0.00 Mn | -2.26 Bn |
| 220 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.87 | — | 0.14 Bn |
| 221 | MED | Medifast Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.13 Bn | -5.25 | 0.00 Mn | -0.04 Bn |
| 222 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.37 | — | 0.13 Bn |
| 223 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.29 | 0.00 Mn | 0.10 Bn |
| 224 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.25 | 0.00 Mn | 0.08 Bn |
| 225 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -6.10 | 0.00 Mn | 0.10 Bn |
| 226 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.23 | — | 0.10 Bn |
| 227 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.52 | 0.00 Mn | 0.10 Bn |
| 228 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.56 | — | 0.03 Bn |
| 229 | TENX | Tenax Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.49 | — | 0.10 Bn |
| 230 | CPIX | Cumberland Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.92 | 0.00 Mn | 0.09 Bn |
| 231 | NTHI | Neonc Technologies Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.05 | — | 0.09 Bn |
| 232 | CGTX | Cognition Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.46 | — | 0.09 Bn |
| 233 | MNOV | Medicinova Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.58 | 0.00 Mn | 0.09 Bn |
| 234 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.73 | — | 0.08 Bn |
| 235 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 0.00 Mn | 0.06 Bn |
| 236 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.12 | 0.00 Mn | -0.11 Bn |
| 237 | LFVN | Lifevantage Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.08 Bn | 16.99 | 0.00 Mn | 0.07 Bn |
| 238 | RGC | Regencell Bioscience Holdings Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 239 | PMVP | PMV Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.19 | — | -0.01 Bn |
| 240 | PLRX | Pliant Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 241 | GWLL | Goldenwell Biotech, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.07 Bn | -574.97 | 1.26 Mn | 0.07 Bn |
| 242 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.08 | 0.00 Mn | 0.06 Bn |
| 243 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.62 | — | 0.07 Bn |
| 244 | CWBHF | Charlotte's Web Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.07 Bn | -1.94 | 0.00 Mn | 0.05 Bn |
| 245 | UPXI | Upexi, Inc. | secondary | T-59 | Fintech | TG-09 | 0.07 Bn | -0.27 | 0.00 Mn | 0.06 Bn |
| 246 | BOLD | Boundless Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 247 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.84 | 0.00 Mn | 0.05 Bn |
| 248 | HAIN | Hain Celestial Group Inc | secondary | S-04 | Branded Foods | SG-02 | 0.06 Bn | -0.15 | 0.00 Mn | 0.02 Bn |
| 249 | VERU | Veru Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 117.37 | — | 0.03 Bn |
| 250 | LEEEF | Leef Brands Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.06 Bn | -12.39 | 0.00 Mn | 0.05 Bn |
| 251 | IBO | Impact Biomedical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -2.87 | 0.00 Mn | 0.05 Bn |
| 252 | GOSS | Gossamer Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.00 Mn | -0.01 Bn |
| 253 | KPTI | Karyopharm Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.24 | 0.00 Mn | -0.02 Bn |
| 254 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.68 | 0.00 Mn | 0.05 Bn |
| 255 | ANVS | Annovis Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.97 | — | 0.05 Bn |
| 256 | ABLV | Able View Global Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.05 Bn | 13.49 | 0.00 Mn | 0.04 Bn |
| 257 | CLNN | Clene Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.33 | 0.00 Mn | 0.04 Bn |
| 258 | LSF | Laird Superfood, Inc. | secondary | S-03 | Beverages | SG-01 | 0.04 Bn | -8.09 | 0.00 Mn | 0.02 Bn |
| 259 | GROV | Grove Collaborative Holdings, Inc. | secondary | S-10 | Household and Personal Products | SG-05 | 0.04 Bn | -5.39 | 0.00 Mn | 0.03 Bn |
| 260 | APRE | Aprea Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.39 | — | 0.04 Bn |
| 261 | BTMD | biote Corp. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.48 | 0.00 Mn | 0.03 Bn |
| 262 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.85 | — | 0.04 Bn |
| 263 | BODI | Beachbody Company, Inc. | secondary | T-48 | Internet Platforms | TG-08 | 0.04 Bn | — | — | 0.00 Bn |
| 264 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.41 | 0.00 Mn | 0.03 Bn |
| 265 | PETS | Petmed Express Inc | secondary | S-14 | Staples Retail | SG-06 | 0.04 Bn | -1.28 | 0.00 Mn | 0.02 Bn |
| 266 | GRCE | Grace Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.86 | — | 0.04 Bn |
| 267 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 0.00 Mn | -0.08 Bn |
| 268 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 0.00 Mn | 0.03 Bn |
| 269 | CPHI | China Pharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.54 | 0.00 Mn | 0.03 Bn |
| 270 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.04 Bn |
| 271 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.09 | 0.00 Mn | 0.02 Bn |
| 272 | UG | United Guardian Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.47 | 0.00 Mn | 0.02 Bn |
| 273 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.00 Mn | 0.03 Bn |
| 274 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | -0.88 | 0.00 Mn | 0.03 Bn |
| 275 | ACTU | Actuate Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.52 | — | 0.03 Bn |
| 276 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.00 Mn | 0.03 Bn |
| 277 | HAFG | Holistic Asset Finance Group Co., Ltd. | secondary | C-04 | Advertising and Media | CG-02 | 0.03 Bn | -269.75 | 0.00 Mn | 0.03 Bn |
| 278 | IGC | IGC Pharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -12.26 | 0.00 Mn | 0.03 Bn |
| 279 | RAPH | Raphael Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -23.02 | — | 0.03 Bn |
| 280 | ANKM | Ankam, Inc. | secondary | T-18 | Business Applications | TG-03 | 0.03 Bn | -83.84 | 0.00 Mn | 0.03 Bn |
| 281 | INVU | Investview, Inc. | secondary | T-64 | Technology Services | TG-11 | 0.03 Bn | -2.03 | 0.00 Mn | 0.02 Bn |
| 282 | NSRX | Nasus Pharma Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 283 | CRVO | CervoMed Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.84 | 0.00 Mn | 0.03 Bn |
| 284 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.61 | — | 0.03 Bn |
| 285 | BYSI | BeyondSpring Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.95 | — | 0.02 Bn |
| 286 | YARW | Yarrow Bioscience, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.18 | 0.00 Mn | 0.00 Bn |
| 287 | TXMD | TherapeuticsMD, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -133.26 | 0.00 Mn | 0.02 Bn |
| 288 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.74 | 0.00 Mn | 0.00 Bn |
| 289 | STCB | Starco Brands, Inc. | secondary | S-04 | Branded Foods | SG-02 | 0.02 Bn | -0.96 | 0.00 Mn | 0.02 Bn |
| 290 | ATOS | Atossa Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.72 | — | 0.02 Bn |
| 291 | CFOO | China Foods Holdings Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -75.98 | 0.00 Mn | 0.02 Bn |
| 292 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.89 | 0.00 Mn | 0.01 Bn |
| 293 | ALLR | Allarity Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.68 | 0.00 Mn | 0.02 Bn |
| 294 | BFRI | Biofrontera Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.31 | 0.00 Mn | 0.02 Bn |
| 295 | MIRA | Mira Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.57 | — | 0.01 Bn |
| 296 | TVRD | Tvardi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.68 | — | 0.02 Bn |
| 297 | DSY | Big Tree Cloud Holdings Ltd | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | — | — | 0.01 Bn |
| 298 | MTEX | Mannatech Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -1.10 | 0.00 Mn | 0.01 Bn |
| 299 | HYEX | Healthy Extracts Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -18.49 | 0.00 Mn | 0.02 Bn |
| 300 | KPRX | Kiora Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.42 | — | 0.02 Bn |